Publicaciones en colaboración con investigadores/as de National Cancer Institute (33)

2023

  1. A pleiotropic variant in DNAJB4 is associated with multiple myeloma risk

    International Journal of Cancer, Vol. 152, Núm. 2, pp. 239-248

  2. Identification of novel genetic loci for risk of multiple myeloma by functional annotation

    Leukemia

  3. Polymorphisms within Autophagy-Related Genes as Susceptibility Biomarkers for Multiple Myeloma: A Meta-Analysis of Three Large Cohorts and Functional Characterization

    International Journal of Molecular Sciences, Vol. 24, Núm. 10

  4. Report of Consensus Panel 3 from the 11th International workshop on Waldenström's Macroglobulinemia: Recommendations for molecular diagnosis in Waldenström's Macroglobulinemia

    Seminars in Hematology

2022

  1. Reaching beyond maximum grade: progress and future directions for modernising the assessment and reporting of adverse events in haematological malignancies

    The Lancet. Haematology, Vol. 9, Núm. 5, pp. e374-e384

  2. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee

    Blood, Vol. 140, Núm. 11, pp. 1229-1253

2021

  1. Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients

    International Journal of Cancer, Vol. 149, Núm. 2, pp. 327-336

  2. Minimal residual disease in Myeloma: Application for clinical care and new drug registration

    Clinical Cancer Research, Vol. 27, Núm. 19, pp. 5195-5212

2018

  1. Beyond maximum grade: modernising the assessment and reporting of adverse events in haematological malignancies

    The Lancet Haematology, Vol. 5, Núm. 11, pp. e563-e598

2017

  1. Changes in bone turnover markers with HIV seroconversion and ART initiation

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 5, pp. 1456-1461

2016

  1. Consensus guidelines for myeloma minimal residual disease sample staining and data acquisition

    Cytometry Part B - Clinical Cytometry, Vol. 90, Núm. 1, pp. 26-30

  2. Recommendations for the diagnosis and initial evaluation of patients with Waldenström Macroglobulinaemia: A Task Force from the 8th International Workshop on Waldenström Macroglobulinaemia

    British Journal of Haematology, Vol. 175, Núm. 1, pp. 77-86

2015

  1. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An International Myeloma Working Group report

    Blood, Vol. 125, Núm. 13, pp. 2068-2074

2014

  1. Detection and outcome of occult leptomeningeal disease in diffuse large B-cell lymphoma and Burkitt lymphoma

    Haematologica, Vol. 99, Núm. 7, pp. 1228-1235

  2. Inaccuracy of haemoglobin A1c among HIV-infected men: Effects of CD4 cell count, antiretroviral therapies and haematological parameters

    Journal of Antimicrobial Chemotherapy, Vol. 69, Núm. 12, pp. 3360-3367

  3. Treatment recommendations for patients with Waldenström macroglobulinemia (WM) and related disorders: IWWM-7 consensus

    Blood, Vol. 124, Núm. 9, pp. 1404-1411

2013

  1. Functional redundancy of Sos1 and Sos2 for lymphopoiesis and organismal homeostasis and survival

    Molecular and Cellular Biology, Vol. 33, Núm. 22, pp. 4562-4578

  2. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 110, Núm. 45, pp. 18250-18255

2012

  1. IMWG consensus on maintenance therapy in multiple myeloma

    Blood, Vol. 119, Núm. 13, pp. 3003-3015

2010

  1. Commentary: Comparison of current flow cytometry methods for monoclonal B cell lymphocytosis detection

    Cytometry Part B - Clinical Cytometry